Alemtuzumab en es it fr

Alemtuzumab Brand names, Alemtuzumab Analogs

Alemtuzumab Brand Names Mixture

  • Locacorten Vioform (Clioquinol + Flumethasone Pivalate)
  • Locacorten Vioform Cream (Clioquinol + Flumethasone Pivalate)
  • Locacorten Vioform Eardrops (Clioquinol + Flumethasone Pivalate)
  • Locasalen (Flumethasone Pivalate + Salicylic Acid)

Alemtuzumab Chemical_Formula


Alemtuzumab RX_link

Alemtuzumab fda sheet

Alemtuzumab msds (material safety sheet)

Alemtuzumab MSDS

Alemtuzumab Synthesis Reference

No information avaliable

Alemtuzumab Molecular Weight


Alemtuzumab Melting Point

61 oC (FAB fragment), 71 oC (whole mAb) ??“ Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Alemtuzumab H2O Solubility

No information avaliable

Alemtuzumab State


Alemtuzumab LogP


Alemtuzumab Dosage Forms

No information avaliable

Alemtuzumab Indication

For treatment of B-cell chronic lymphocytic leukemia

Alemtuzumab Pharmacology

Campath is used to treat leukemia by exploiting antibody mediated lysis of CD52 presenting cells. The CD52 antigen is a cell surface protein found on essentially all B and T lymphocytes, a majority of monocytes, macrophages and most granulocytes. The CD52 antigen is not present on erythrocytes or hematopoetic stem cells. In leukemia there is an excess of B and T cells, so Campath permits selective reduction of lymphocyte populations.

Alemtuzumab Absorption

No information avaliable

Alemtuzumab side effects and Toxicity

No information avaliable

Alemtuzumab Patient Information

No information avaliable

Alemtuzumab Organisms Affected

No information avaliable